CVAT — what changed in the latest 10-Q
A section-by-section comparison of CVAT's newest periodic SEC filing (10-K/10-Q) against the prior same-form filing: paragraphs added and removed per section, with verbatim excerpts. Purely a deterministic text diff — no similarity scores, no directional read, not investment advice.
Comparing 10-Q · 2026-05-20 vs the prior 10-Q · 2026-02-17
| Section | Outcome | Added | Removed | Minor | Unchanged |
|---|---|---|---|---|---|
| MD&A | Text added/removed | +22 | −19 | ~14 | 47 |
| Controls & procedures | Text added/removed | 0 | 0 | ~2 | 1 |
| Legal proceedings | No paragraph-level changes | 0 | 0 | 0 | 1 |
| Other information | Text added/removed | 0 | 0 | ~1 | 0 |
Counts are paragraphs; added/removed means text added or removed vs the prior filing — no direction or judgement implied.
Not shown (absent or not faithfully extractable): Market risk (Item 3), Risk factors
Representative excerpts
Up to 5 excerpts of about 300 characters per section, quoted verbatim from the two SEC filings.
MD&A
Text added vs the prior filing · source: 10-Q · 2026-05-20
· Stock compensation decreased by $90,000. In the prior year warrants were issued to three consultants,
· Professional fees decreased by $6,000, primarily due to a decrease in legal related expenses,
· Consulting fees increased by $38,000 primarily due to consulting fees incurred in Xyra Corporation during the current year,
· Payroll expenses increased by $4,000 due to slight salary increases to our employees,
Interest expense was $3,000 and $2,000 for the three months ended March 31, 2026 and 2025, the increase is primarily related to interest incurred on convertible notes and related party notes advanced to the Company.
Text removed vs the prior filing · source: 10-Q · 2026-02-17
· Stock compensation increased by $139,000. The current year stock compensation related to the fair value of common stock issued to certain consultants. In the prior year warrants were issued to the Company’s employees and a consultant,
· Professional fees decreased by $25,000, primarily due to a decrease in attorney fees of $42,000 related to a reduction in patent attorney expenses, offset by an increase in audit fees of $11,000 and other professional fees of $6,000 related to the timing of work performed,
· Payroll expenses increased by $6,000 due to slight salary increases to our employees.,
· Rent expense increased by $2,000, the property lease became a month-to-month lease at an increased rate after the expiry of the previous lease term.
Gain on patent assignment was $0 and $880,000 for the three months ended December 31, 2025 and 2024, respectively. The prior year gain on patent assignment was as a result of sale and assignment of certain patents to Desmet. There were no similar transaction during the period ended December 31, 2025…
How to read Risk Factors (Item 1A) in a 10-Q
A 10-Q risk-factor section usually takes one of three forms; this page classifies it as one of:
- Pointer — the filer states there have been no material changes and points back to the annual 10-K risk factors; there is no own risk text to compare this quarter.
- Partial update — the filer carves out specific updated risks ("except as set forth below"); the excerpts show exactly what is new this quarter.
- Restated in full — the quarter carries the complete risk-factor text. When the prior quarter was only a pointer there is no prior full text to diff against, so the page flags the section as restated instead.
This describes the filing structure only — it is never a judgement on whether risk went up or down.
Source: text-level diff of the two SEC EDGAR filings · deterministic (no AI-generated content) · for reference only · not investment advice